Latest filings (excl ownership)
15-12G
Securities registration termination
13 Nov 23
EFFECT
Notice of effectiveness
10 Oct 23
EFFECT
Notice of effectiveness
10 Oct 23
EFFECT
Notice of effectiveness
6 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Oct 23
POS AM
Prospectus update (post-effective amendment)
2 Oct 23
POS AM
Prospectus update (post-effective amendment)
2 Oct 23
POS AM
Prospectus update (post-effective amendment)
2 Oct 23
8-K
Bankruptcy or Receivership
29 Sep 23
8-K
Entry into a Material Definitive Agreement
18 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
8-K
Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales
1 Aug 23
25-NSE
Exchange delisting
27 Jul 23
8-K
Regulation FD Disclosure
23 Jun 23
8-K
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing
23 Jun 23
8-K
Entry into a Material Definitive Agreement
20 Jun 23
8-K
Cost Associated with Exit or Disposal Activities
16 Jun 23
8-K
Departure of Directors or Certain Officers
15 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Jun 23
8-K
Other Events
30 May 23
8-K
Termination of a Material Definitive Agreement
22 May 23
8-K
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
11 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Apr 23
8-K
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
30 Mar 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Other Events
16 Mar 23
8-K/A
Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance
6 Mar 23
8-K
Entry into a Material Definitive Agreement
6 Mar 23
8-K
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
1 Mar 23
8-K
Amendments to Articles of Incorporation or Bylaws
22 Dec 22
424B3
Prospectus supplement
16 Nov 22
424B3
Prospectus supplement
16 Nov 22
424B5
Prospectus supplement for primary offering
15 Nov 22
8-K
Surgalign Announces $12.0 Million Registered Direct Offering
15 Nov 22
8-K
Cost Associated with Exit or Disposal Activities
9 Nov 22
Latest ownership filings
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
David Lyle
18 Sep 23
4
Paolo Amoruso
5 Sep 23
4
Christopher Thunander
16 Aug 23
4
Enrico Sangiorgio
16 Aug 23
4
Terry M. Rich
16 Aug 23
4
Marc E. Mackey
16 Aug 23
4
David Lyle
16 Aug 23
4
Christopher Thunander
9 Aug 23
4
Enrico Sangiorgio
9 Aug 23
4
Terry M. Rich
9 Aug 23
3
Elizabeth A. LaPuma
22 Jun 23
3
Jill Kathleen Frizzley
22 Jun 23
4
David Lyle
16 Jun 23
4
Enrico Sangiorgio
8 May 23
4
Terry M. Rich
8 May 23
4
William Scott Durall
8 May 23
4
William Scott Durall
4 Apr 23
4
David Lyle
16 Mar 23
4
Enrico Sangiorgio
28 Feb 23
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 23
4
Enrico Sangiorgio
9 Feb 23
4
Terry M. Rich
9 Feb 23
4
William Scott Durall
9 Feb 23
4
Terry M. Rich
17 Jan 23
4
Terry M. Rich
3 Jan 23
4
Terry M. Rich
9 Nov 22
4
Enrico Sangiorgio
9 Nov 22
4
Paolo Amoruso
6 Sep 22
4
William Scott Durall
17 Aug 22
4
Christopher Thunander
17 Aug 22
4
Enrico Sangiorgio
17 Aug 22
4
Terry M. Rich
17 Aug 22
4
Marc E. Mackey
17 Aug 22
4
David Lyle
17 Aug 22
4
NICHOLAS J VALERIANI
17 Aug 22
4
PAUL THOMAS
17 Aug 22
4
MARK STOLPER
17 Aug 22
4
Thomas McEachin
17 Aug 22
4
SHERYL L CONLEY
17 Aug 22